We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Ancestors of the CRISPR-Cas System Are Reconstructed

Representation of genome editing with hands changing DNA with tweezers and scissors.
Credit: iStock

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ancestors of the CRISPR-Cas System Are Reconstructed"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

An international research group, with the participation of UPF, has for the first time reconstructed ancestors dating back 2.6 billion years of the well-known CRISPR-Cas system, and studied their evolution over time. The results suggest that the revitalized systems not only work, but are more versatile than current versions and could have revolutionary applications. An article  of the prestigious scientific journal Nature Microbiology has published the results of this research which, in the opinion of the research team, “opens up new avenues for gene editing”


The project, led by Ikerbasque research professor Rául Pérez-Jiménez of  CIC nanoGUNE, involved teams from the Spanish National Research Council, the University of Alicante, the Rare Diseases Networking Biomedical Research Center (CIBERER), and other national and international institutions. The director of the Translational Synthetic Biology of the UPF, Marc Güell, has participated in this study, together with Avencia Sánchez-Mejías, who worked in this same University research group.


The repeated sequences CRISPR of the microorganisms harbor fragments of genetic material from viruses that infected their ancestors, that enables them to recognize a repeat infection and defend themselves by cutting the invaders' DNA using Cas proteins associated with these repeats.


The acronym CRISPR refers to the repeated sequences present in the DNA of bacteria and archaea (prokaryotic organisms). Among the repeats, these microorganisms harbor fragments of genetic material from viruses that infected their ancestors; that enables them to recognize a repeat infection and defend themselves by cutting the invaders' DNA using Cas proteins associated with these repeats. It is a mechanism (CRISPR-Cas system) of antiviral defense. This ability to recognize DNA sequences is the basis of their usefulness, and they act as if they were molecular scissors. CRISPR-Cas technology nowadays enables pieces of genetic material to be cut and pasted into any cell, so that it can be used to edit DNA.


A radically different approach to finding new systems is to look for them in the past, which is in fact the basis of this research.


Current research efforts focus on finding new versions of CRISPR-Cas systems with distinct properties in the farthest reaches of the globe. To do this, systems of different species living in extreme environments are explored, or molecular design techniques are applied to modify them. A radically different approach to finding new systems is to look for them in the past, which is in fact the basis of this research.

Marc Güell (UPF): "This study strategy contrasts with the classical one, which consists on the search for CRISPR enzymes in nature nowadays.  On the contrary, this study goes back to the past in order to identify CRISPR systems with very interesting properties"

The Nanobiotechnology group at nanoGUNE, led by Raúl Pérez-Jiménez, has spent years studying the evolution of proteins from the origin of life right up to the present day. Ancestral reconstructions of proteins and genes from extinct organisms are carried out to see what qualities they have and whether they can be used in biotechnological applications. It is a journey back in time conducted by means of biocomputing techniques. In this work, which has just been published in the journal Nature Microbiology, the evolutionary history of CRISPR-Cas systems, from ancestors dating back 2.6 billion years to the present day have been reconstructed for the first time.


In the same way, Marc Güell (UPF) assures: "This study strategy contrasts with the classical one, which consists on the search for CRISPR enzymes in nature nowadays.  On the contrary, this study goes back to the past in order to identify CRISPR systems with very interesting properties".

Lluís Montoliu (CSIC and CIBERER): “What is surprising is that we can revitalize Cas proteins that must have existed billions of years ago and find that they already had the capacity then to operate as gene editing tools, something that we have now confirmed by successfully editing genes in human cells”

The research team carried out the computational reconstruction of the ancestral CRISPR sequences, synthesized them, and studied and confirmed their functionality. “What is surprising is that we can revitalize Cas proteins that must have existed billions of years ago and find that they already had the capacity then to operate as gene editing tools, something that we have now confirmed by successfully editing genes in human cells,” explained Lluís Montoliu, researcher at the National Biotechnology Center of the CSIC (CNB-CSIC) and CIBERER, and head of the team that has functionally validated these ancestral Cas proteins in human cells in culture.

Francis Mojica (Universitat d’Alacant): “This research signifies an extraordinary advance in knowledge about the origin and evolution of CRISPR-Cas systems, and in how the selective pressure of viruses has over billions of years been fine-tuning rudimentary, initially not very selective machinery; this had been taking place until a sophisticated defense mechanism was produced”

Another interesting finding of the study is that the CRISPR-Cas system has gradually become more complex over time, which is a sign of the adaptive nature of the system; it has been gradually adapting to new virus threats that have been hanging over bacteria throughout evolution. “This research signifies an extraordinary advance in knowledge about the origin and evolution of CRISPR-Cas systems, and in how the selective pressure of viruses has over billions of years been fine-tuning rudimentary, initially not very selective machinery; this had been taking place until a sophisticated defense mechanism was produced; a  mechanism capable of distinguishing with great precision between its own DNA, which it must preserve, and the genetic material of unwanted invaders, which it must destroy,” added the University of Alicante researcher who discovered the CRISPR-Cas technique, Francis Mojica. On the applied side, “the work represents an original approach to the development of CRISPR tools to generate new tools and improve those derived from existing ones in current organisms,” added Mojica.


“Current systems are highly complex and are adapted to function within a bacterium. When the system is used outside this environment, for example in human cells, it is rejected by the immune system and there are also certain molecular restrictions that limit its use. Oddly enough, in ancestral systems some of these restrictions disappear, which gives these systems greater versatility for new applications,” as Pérez-Jiménez pointed out.


Miguel Angel Moreno, head of the Genetics Service at HRYC-IRYCIS-CIBERER, pointed out that "the ingenuity that an ancestral nuclease could have, insofar as it does not so specifically recognize some regions of the genome, turns them into more versatile tools for correcting mutations that until now could not be edited or were not corrected very efficiently". His team has developed the Mosaic Finder tool, which, by means of massive sequencing and bioinformatics analysis, has enabled the effect of genome editing carried out by these ancestral Cas in human cells in culture to be characterized.


The research opens up new avenues in DNA manipulation and treatment of diseases such as ALS, cancer and diabetes, or even in diagnostic tools for diseases


Ylenia Jabalera, researcher in the project at nanoGUNE, says that “this scientific achievement can make available gene editing tools with properties different from the current ones, and which are much more flexible; that opens up new avenues in DNA manipulation and treatment of diseases such as ALS, cancer and diabetes, or even in diagnostic tools for diseases”. 


Reference: Alonso-Lerma B, Jabalera Y, Samperio S, et al. Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins. Nat Microbiol. 2023:1-14. doi: 10.1038/s41564-022-01265-y


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.


Advertisement